SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RGLS, KRON, XAGE, SSBK on Behalf of ShareholdersGlobeNewswireMay 15, 2025NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Regulus Therapeutics Inc. (NASDAQ: RGLS)'s sale to Novartis AG. Under the terms of the proposed transaction, Regulus shareholders will receive $7.00 per share in cash and a contingent value right providing for payment of $7.00 per share, contingent upon the achievement of a milestone with respect to regulatory approval of Regulus' lead product candidate, farabursen. If you are a Regulus shareholder, click here to learn more about your rights and options.
Kronos Bio, Inc. (NASDAQ: KRON)'s sale to Concentra Biosciences, LLC for $0.57 in cash per share plus one non-tradeable contingent value right. If you are a Kronos shareholder, click here to learn more about your rights and options.
Longevity Health Holdings, Inc. (NASDAQ: XAGE)'s merger with 20/20 BioLabs, Inc. Upon closing of the proposed transaction, Longevity shareholders are expected to own approximately 49.9% of the combined company. If you are a Longevity shareholder, click here to learn more about your rights and options.
Southern States Bancshares, Inc. (NASDAQ: SSBK)'s sale to FB Financial Corporation for 0.800 shares of FB Financial common stock for each share of Southern States stock. If you are a Southern States shareholder, click here to learn more about your legal rights and options.
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:Halper Sadeh LLCDaniel Sadeh, Esq.Zachary Halper, Esq.One World Trade Center85th FloorNew York, NY 10007(212) 763-0060sadeh@halpersadeh.comzhalper@halpersadeh.comhttps://www.halpersadeh.com
COMTEX_465536703/2010/2025-05-15T18:52:17
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Regulus Therapeutics Inc. (NASDAQ: RGLS)'s sale to Novartis AG. Under the terms of the proposed transaction, Regulus shareholders will receive $7.00 per share in cash and a contingent value right providing for payment of $7.00 per share, contingent upon the achievement of a milestone with respect to regulatory approval of Regulus' lead product candidate, farabursen. If you are a Regulus shareholder, click here to learn more about your rights and options.
Kronos Bio, Inc. (NASDAQ: KRON)'s sale to Concentra Biosciences, LLC for $0.57 in cash per share plus one non-tradeable contingent value right. If you are a Kronos shareholder, click here to learn more about your rights and options.
Longevity Health Holdings, Inc. (NASDAQ: XAGE)'s merger with 20/20 BioLabs, Inc. Upon closing of the proposed transaction, Longevity shareholders are expected to own approximately 49.9% of the combined company. If you are a Longevity shareholder, click here to learn more about your rights and options.
Southern States Bancshares, Inc. (NASDAQ: SSBK)'s sale to FB Financial Corporation for 0.800 shares of FB Financial common stock for each share of Southern States stock. If you are a Southern States shareholder, click here to learn more about your legal rights and options.
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:Halper Sadeh LLCDaniel Sadeh, Esq.Zachary Halper, Esq.One World Trade Center85th FloorNew York, NY 10007(212) 763-0060sadeh@halpersadeh.comzhalper@halpersadeh.comhttps://www.halpersadeh.com
COMTEX_465536703/2010/2025-05-15T18:52:17
7.54% $0.43
